NCT06432530View on ClinicalTrials.gov

Can Hematological Inflammatory Indexes be Used to Differentiate Type 1 Modic Changes From Brucella Spondylodiscitis

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

September 15, 2023

Study Completion Date

March 8, 2024

Conditions
Brucella Spondylitis
Interventions
OTHER

C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Complete Blood Count (CBC) values, and indexes derived from the CBC.

Patients' hematological parameters were recorded, and hematological inflammatory indexes (NLR: neutrophil/lymphocyte; MLR: monocyte/lymphocyte; PLR: platelet/lymphocyte; NLPR: neutrophil/(lymphocyte\*platelet); SII (neutrophil\*platelet/lymphocyte): systemic inflammatory index; SIRI (neutrophil\*monocyte/lymphocyte): systemic inflammatory response index; AISI (neutrophil\*platelet\*monocyte/lymphocyte): aggregate index of systemic inflammation. ) were derived from baseline CBC tests.

Trial Locations (1)

65040

Volkan Şah, Van

All Listed Sponsors
lead

Yuzuncu Yıl University

OTHER